US Government’s medical marijuana patent
From DigitalJournal.com
“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases.Thecannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”
Read Full Article
Related Articles
Next Gold Rush: Legal Marijuana Feeds Entrepreneurs’ Dreams
Article by Jack Healy and Kirk Johnson, New York Times – July 18, 2014 DENVER — “Like the glint of
Medical Marijuana Pros and Cons
Should Marijuana Be a Medical Option? In 1972, the US Congress placed marijuana in Schedule I of the Controlled Substances
